Close Menu

MDxHealth

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MDx Health today reported that revenues in the third quarter declined 43 percent year over year.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MDx Health today reported an 8 percent increase in first-half 2011 revenues as commercial revenues rose 19 percent.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MDx Health today announced the signing of a lease agreement for a laboratory and office facilities in Irvine, Calif.

A new study provides further support for MDxHealth's PredictMDx brain cancer test, which predicts which patients will respond to the alkylating chemotherapy temozolomide.

A sampling of molecular diagnostics and pharmacogenomics abstracts presented at the American Society of Clinical Oncology's annual meeting.

Merck will continue use of MDxHealth's MGMT assay in a clinical trial for its integrin inhibitor cilengitide for patients with glioblastoma with a methylated promoter of the MGMT gene.

The Belgian company attributed the sharp decline to a drop in grant revenues as the company moved away from basic research to molecular diagnostics development during the past year.

The firms will use the grant to discover and validate tumor markers that may be predictive of tumor progression into the muscle in developing invasive-stage bladder cancer.

Biovest is an investment firm led by Innogenetics Co-founder and Chairman Rudi Mariën.

MDxHealth said its current cash position and newly raised funds will help it expand its presence in the US by opening a new CLIA lab and hiring a sales force.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.